Investor · Cambridge
Ahren Innovation Capital
Deep science investor founded by scientists and entrepreneurs, investing across long-horizon technologies.
Investment profile
Stage
- Seed
- Series A
- Series B
Investment type
- Venture capital
Geographic mandate
Global
Typical cheque size is shown only where the investor publishes it. Where it is absent, it is not published rather than estimated.
Connected ecosystem
Companies in the same place and sectors
- Arm
Processor architecture and semiconductor IP company whose designs are licensed into the majority of the world's mobile devices.
- Paragraf
Manufactures graphene-based electronic devices using a contamination-free production process.
- Nyobolt
Develops fast-charging battery systems based on niobium tungsten oxide anode materials.
- Bicycle Therapeutics
Develops bicyclic peptide therapeutics, with research operations on the Cambridge biomedical campus.
- Congenica
Clinical genomics software used to interpret genomic data in diagnostic settings.
- AstraZeneca
Global pharmaceutical company with its strategic research centre and headquarters in Cambridge.
- Darktrace
Cambridge-founded cyber security company applying machine learning to network defence, now under international private ownership.
- Quantinuum
Quantum computing company with significant Cambridge software and research operations within an international group.
Universities in Cambridge
Relevant proposed UKIZ missions
Listing does not imply participation. No investor here is a UKIZ participant unless stated on the UKIZ people page.
Proposed by UKIZ · not a government designation
Sources
- Organisation's own published material
Last verified: 15 August 2026